<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39460349</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>17</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>ASIA Syndrome: State-of-the-Art and Future Perspectives.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1183</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines12101183</ELocationID><Abstract><AbstractText>The expression "Autoimmune/inflammatory syndrome induced by adjuvants (ASIA)" was coined by Shoenfeld and colleagues in 2011. It defines a group of immune-mediated disorders that arise in people, with a genetic predisposition, following exposure to adjuvant agents. This syndrome has been reported after contact with silicone implants, medications, infections, metals, vaccines, and other substances. It typically occurs in individuals with a genetic predisposition, particularly involving genes, such as <i>HLA-DRB1</i> (major histocompatibility complex, class II, DR beta 1) and <i>PTPN22</i> (protein tyrosine phosphatase non-receptor type 22). Some stimuli lead to an overactivation of the immune system, prompt the production of autoantibodies, and finally cause autoimmune disorders. This narrative review aims to provide an overview of the ASIA syndrome with a special focus on the role of adjuvants in different vaccines, especially after the COVID-19 pandemic, and insights into development of new treatments.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Caldarelli</LastName><ForeName>Mario</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5308-7072</Identifier><AffiliationInfo><Affiliation>Department of Translational Medicine and Surgery, Catholic University of Sacred Heart, 00168 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rio</LastName><ForeName>Pierluigi</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-8659-3091</Identifier><AffiliationInfo><Affiliation>Department of Translational Medicine and Surgery, Catholic University of Sacred Heart, 00168 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giambra</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-2607-2080</Identifier><AffiliationInfo><Affiliation>Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapies (ISBReMIT), Fondazione IRCCS "Casa Sollievo della Sofferenza", 71013 San Giovanni Rotondo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gasbarrini</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6230-1779</Identifier><AffiliationInfo><Affiliation>Department of Translational Medicine and Surgery, Catholic University of Sacred Heart, 00168 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gambassi</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Translational Medicine and Surgery, Catholic University of Sacred Heart, 00168 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cianci</LastName><ForeName>Rossella</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-5378-8442</Identifier><AffiliationInfo><Affiliation>Department of Translational Medicine and Surgery, Catholic University of Sacred Heart, 00168 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ASIA</Keyword><Keyword MajorTopicYN="N">adjuvants</Keyword><Keyword MajorTopicYN="N">genetic predisposition</Keyword><Keyword MajorTopicYN="N">immune system</Keyword><Keyword MajorTopicYN="N">vaccines</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39460349</ArticleId><ArticleId IdType="pmc">PMC11511404</ArticleId><ArticleId IdType="doi">10.3390/vaccines12101183</ArticleId><ArticleId IdType="pii">vaccines12101183</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shoenfeld Y., Agmon-Levin N. “ASIA”—Autoimmune/Inflammatory Syndrome Induced by Adjuvants. J. Autoimmun. 2011;36:4–8. doi: 10.1016/j.jaut.2010.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2010.07.003</ArticleId><ArticleId IdType="pubmed">20708902</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres-Saavedra F.A., León-Sierra L.P., Rondón-Carvajal J. ASIA Syndrome (Autoimmune/Inflammatory Syndrome Induced by Adjuvants): Narrative Literature Review. Rev. Colomb. Reumatol. Engl. Ed. 2024;31:380–389. doi: 10.1016/j.rcreue.2024.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rcreue.2024.07.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Bindoli S., Giollo A., Galozzi P., Doria A., Sfriso P. Hyperinflammation after Anti-SARS-CoV-2 mRNA/DNA Vaccines Successfully Treated with Anakinra: Case Series and Literature Review. Exp. Biol. Med. 2022;247:338–344. doi: 10.1177/15353702211070290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/15353702211070290</ArticleId><ArticleId IdType="pmc">PMC8899337</ArticleId><ArticleId IdType="pubmed">35068221</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H., Yan S., Chen J., Luo X., Li P., Jia X., Dai X., Wang C., Huang Q., Liu L., et al. JAK1-STAT3 Blockade by JAK Inhibitor SHR0302 Attenuates Inflammatory Responses of Adjuvant-Induced Arthritis Rats and Decreases Th17 and Total B Cells. Joint Bone Spine. 2016;83:525–532. doi: 10.1016/j.jbspin.2015.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbspin.2015.09.002</ArticleId><ArticleId IdType="pubmed">26832189</ArticleId></ArticleIdList></Reference><Reference><Citation>Colafrancesco S., Agmon-Levin N., Perricone C., Shoenfeld Y. Unraveling the Soul of Autoimmune Diseases: Pathogenesis, Diagnosis and Treatment Adding Dowels to the Puzzle. Immunol. Res. 2013;56:200–205. doi: 10.1007/s12026-013-8429-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-013-8429-4</ArticleId><ArticleId IdType="pubmed">23733136</ArticleId></ArticleIdList></Reference><Reference><Citation>Israeli E. Gulf War Syndrome as a Part of the Autoimmune (Autoinflammatory) Syndrome Induced by Adjuvant (ASIA) Lupus. 2012;21:190–194. doi: 10.1177/0961203311429552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203311429552</ArticleId><ArticleId IdType="pubmed">22235052</ArticleId></ArticleIdList></Reference><Reference><Citation>Masson J.-D., Badran G., Gherardi R.K., Authier F.-J., Crépeaux G. Widespread Myalgia and Chronic Fatigue: Phagocytes from Macrophagic Myofasciitis Patients Exposed to Aluminum Oxyhydroxide-Adjuvanted Vaccine Exhibit Specific Inflammatory, Autophagic, and Mitochondrial Responses. Toxics. 2024;12:491. doi: 10.3390/toxics12070491.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/toxics12070491</ArticleId><ArticleId IdType="pmc">PMC11281175</ArticleId><ArticleId IdType="pubmed">39058143</ArticleId></ArticleIdList></Reference><Reference><Citation>Masson J.-D., Badran G., Domdom M.A., Gherardi R.K., Mograbi B., Authier F.J., Crépeaux G. Advances on the Early Cellular Events Occurring upon Exposure of Human Macrophages to Aluminum Oxyhydroxide Adjuvant. Sci. Rep. 2023;13:3198. doi: 10.1038/s41598-023-30336-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-30336-1</ArticleId><ArticleId IdType="pmc">PMC9950428</ArticleId><ArticleId IdType="pubmed">36823452</ArticleId></ArticleIdList></Reference><Reference><Citation>Yussuf S.M., Dahir G., Salad A.M., Hayir M.T.M., Hassan S.A., Gele A. Sick Building Syndrome and Its Associated Factors among Adult People Living in Hodan District Moqadishu Somalia. Front. Built Environ. 2023;9:1218659. doi: 10.3389/fbuil.2023.1218659.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fbuil.2023.1218659</ArticleId></ArticleIdList></Reference><Reference><Citation>Meroni P.L. Autoimmune or Auto-Inflammatory Syndrome Induced by Adjuvants (ASIA): Old Truths and a New Syndrome? J. Autoimmun. 2011;36:1–3. doi: 10.1016/j.jaut.2010.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2010.10.004</ArticleId><ArticleId IdType="pubmed">21051205</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S., Zhu H., Xia X., Liang Z., Ma X., Sun B. Vaccine Adjuvants: Understanding the Structure and Mechanism of Adjuvanticity. Vaccine. 2019;37:3167–3178. doi: 10.1016/j.vaccine.2019.04.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2019.04.055</ArticleId><ArticleId IdType="pubmed">31047671</ArticleId></ArticleIdList></Reference><Reference><Citation>Watad A., Quaresma M., Brown S., Cohen Tervaert J.W., Rodríguez-Pint I., Cervera R., Perricone C., Shoenfeld Y. Autoimmune/Inflammatory Syndrome Induced by Adjuvants (Shoenfeld’s Syndrome)—An Update. Lupus. 2017;26:675–681. doi: 10.1177/0961203316686406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203316686406</ArticleId><ArticleId IdType="pubmed">28059022</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahroum N., Lavine N., Ohayon A., Seida R., Alwani A., Alrais M., Zoubi M., Bragazzi N.L. COVID-19 Vaccination and the Rate of Immune and Autoimmune Adverse Events Following Immunization: Insights From a Narrative Literature Review. Front. Immunol. 2022;13:872683. doi: 10.3389/fimmu.2022.872683.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.872683</ArticleId><ArticleId IdType="pmc">PMC9294236</ArticleId><ArticleId IdType="pubmed">35865539</ArticleId></ArticleIdList></Reference><Reference><Citation>Seida I., Seida R., Elsalti A., Mahroum N. Vaccines and Autoimmunity-From Side Effects to ASIA Syndrome. Med. Kaunas Lith. 2023;59:364. doi: 10.3390/medicina59020364.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina59020364</ArticleId><ArticleId IdType="pmc">PMC9966463</ArticleId><ArticleId IdType="pubmed">36837564</ArticleId></ArticleIdList></Reference><Reference><Citation>Jara L.J., García-Collinot G., Medina G., del Pilar Cruz-Dominguez M., Vera-Lastra O., Carranza-Muleiro R.A., Saavedra M.A. Severe Manifestations of Autoimmune Syndrome Induced by Adjuvants (Shoenfeld’s Syndrome) Immunol. Res. 2017;65:8–16. doi: 10.1007/s12026-016-8811-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-016-8811-0</ArticleId><ArticleId IdType="pubmed">27412294</ArticleId></ArticleIdList></Reference><Reference><Citation>Hennekens C.H., Lee I.-M., Cook N.R., Hebert P.R., Karlson E.W., LaMotte F., Manson J.E., Buring J.E. Self-Reported Breast Implants and Connective-Tissue Diseases in Female Health Professionals: A Retrospective Cohort Study. JAMA. 1996;275:616–621. doi: 10.1001/jama.1996.03530320040032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1996.03530320040032</ArticleId><ArticleId IdType="pubmed">8594243</ArticleId></ArticleIdList></Reference><Reference><Citation>Goren I., Segal G., Shoenfeld Y. Autoimmune/Inflammatory Syndrome Induced by Adjuvant (ASIA) Evolution after Silicone Implants. Who Is at Risk? Clin. Rheumatol. 2015;34:1661–1666. doi: 10.1007/s10067-015-2931-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-015-2931-0</ArticleId><ArticleId IdType="pubmed">25877803</ArticleId></ArticleIdList></Reference><Reference><Citation>Ameratunga R., Gillis D., Gold M., Linneberg A., Elwood J.M. Evidence Refuting the Existence of Autoimmune/Autoinflammatory Syndrome Induced by Adjuvants (ASIA) J. Allergy Clin. Immunol. Pract. 2017;5:1551–1555.e1. doi: 10.1016/j.jaip.2017.06.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2017.06.033</ArticleId><ArticleId IdType="pubmed">28888842</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkes D., Benhamu J., Sidwell T., Miles R., Dunlop R.A. Revisiting Adverse Reactions to Vaccines: A Critical Appraisal of Autoimmune Syndrome Induced by Adjuvants (ASIA) J. Autoimmun. 2015;59:77–84. doi: 10.1016/j.jaut.2015.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2015.02.005</ArticleId><ArticleId IdType="pubmed">25794485</ArticleId></ArticleIdList></Reference><Reference><Citation>Watad A., Bragazzi N.L., McGonagle D., Adawi M., Bridgewood C., Damiani G., Alijotas-Reig J., Esteve-Valverde E., Quaresma M., Amital H., et al. Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA) Demonstrates Distinct Autoimmune and Autoinflammatory Disease Associations According to the Adjuvant Subtype: Insights from an Analysis of 500 Cases. Clin. Immunol. Orlando Fla. 2019;203:1–8. doi: 10.1016/j.clim.2019.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2019.03.007</ArticleId><ArticleId IdType="pubmed">30922961</ArticleId></ArticleIdList></Reference><Reference><Citation>Borba V., Malkova A., Basantsova N., Halpert G., Andreoli L., Tincani A., Amital H., Shoenfeld Y. Classical Examples of the Concept of the ASIA Syndrome. Biomolecules. 2020;10:1436. doi: 10.3390/biom10101436.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom10101436</ArticleId><ArticleId IdType="pmc">PMC7600067</ArticleId><ArticleId IdType="pubmed">33053910</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaefer C.J., Wooley P.H. The Influence of Silicone Implantation on Murine Lupus in MRL Lpr/Lpr Mice. J. Rheumatol. 1999;26:2215–2221.</Citation><ArticleIdList><ArticleId IdType="pubmed">10529143</ArticleId></ArticleIdList></Reference><Reference><Citation>Zandman-Goddard G., Blank M., Ehrenfeld M., Gilburd B., Peter J., Shoenfeld Y. A Comparison of Autoantibody Production in Asymptomatic and Symptomatic Women with Silicone Breast Implants. J. Rheumatol. 1999;26:73–77.</Citation><ArticleIdList><ArticleId IdType="pubmed">9918243</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosca M., Tani C., Talarico R., Bombardieri S. Undifferentiated Connective Tissue Diseases (UCTD): Simplified Systemic Autoimmune Diseases. Autoimmun. Rev. 2011;10:256–258. doi: 10.1016/j.autrev.2010.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2010.09.013</ArticleId><ArticleId IdType="pubmed">20863913</ArticleId></ArticleIdList></Reference><Reference><Citation>Scanzi F., Andreoli L., Martinelli M., Taraborelli M., Cavazzana I., Carabellese N., Ottaviani R., Allegri F., Franceschini F., Agmon-Levin N., et al. Are the Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA) and the Undifferentiated Connective Tissue Disease (UCTD) Related to Each Other? A Case-Control Study of Environmental Exposures. Immunol. Res. 2017;65:150–156. doi: 10.1007/s12026-017-8912-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-017-8912-4</ArticleId><ArticleId IdType="pubmed">28332072</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzarella L., Duso B.A., Trapani D., Belli C., D’Amico P., Ferraro E., Viale G., Curigliano G. The Evolving Landscape of “next-Generation” Immune Checkpoint Inhibitors: A Review. Eur. J. Cancer Oxf. Engl. 1990. 2019;117:14–31. doi: 10.1016/j.ejca.2019.04.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejca.2019.04.035</ArticleId><ArticleId IdType="pubmed">31229946</ArticleId></ArticleIdList></Reference><Reference><Citation>Darnell E.P., Mooradian M.J., Baruch E.N., Yilmaz M., Reynolds K.L. Immune-Related Adverse Events (irAEs): Diagnosis, Management, and Clinical Pearls. Curr. Oncol. Rep. 2020;22:39. doi: 10.1007/s11912-020-0897-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11912-020-0897-9</ArticleId><ArticleId IdType="pubmed">32200442</ArticleId></ArticleIdList></Reference><Reference><Citation>Bragazzi N.L., Hejly A., Watad A., Adawi M., Amital H., Shoenfeld Y. ASIA Syndrome and Endocrine Autoimmune Disorders. Best Pract. Res. Clin. Endocrinol. Metab. 2020;34:101412. doi: 10.1016/j.beem.2020.101412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.beem.2020.101412</ArticleId><ArticleId IdType="pubmed">32265102</ArticleId></ArticleIdList></Reference><Reference><Citation>Vayssairat M., Mimoun M., Houot B., Abuaf N., Rouquette A.M., Chaouat M. Hashimoto’s thyroiditis and silicone breast implants: 2 cases. J. Mal. Vasc. 1997;22:198–199.</Citation><ArticleIdList><ArticleId IdType="pubmed">9303936</ArticleId></ArticleIdList></Reference><Reference><Citation>Mochizuki S., Miura J., Ucida K., Kubota R., Fujikawa H., Takagi S., Yoshida N., Ootake S., Fujimori C., Shinohara A., et al. Type 1 Diabetes Mellitus Following COVID-19 Vaccination: A Report of Two Cases and Review of Literature. Diabetol. Int. 2024;15:577–582. doi: 10.1007/s13340-024-00695-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13340-024-00695-9</ArticleId><ArticleId IdType="pmc">PMC11291814</ArticleId><ArticleId IdType="pubmed">39101197</ArticleId></ArticleIdList></Reference><Reference><Citation>Aydoğan B.İ., Ünlütürk U., Cesur M. Type 1 Diabetes Mellitus Following SARS-CoV-2 mRNA Vaccination. Endocrine. 2022;78:42–46. doi: 10.1007/s12020-022-03130-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-022-03130-8</ArticleId><ArticleId IdType="pmc">PMC9282628</ArticleId><ArticleId IdType="pubmed">35809159</ArticleId></ArticleIdList></Reference><Reference><Citation>Seida I., Alrais M., Seida R., Alwani A., Kiyak Z., Elsalti A., Nil Esirgun S., Abali T., Mahroum N. Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA): Past, Present, and Future Implications. Clin. Exp. Immunol. 2023;213:87–101. doi: 10.1093/cei/uxad033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cei/uxad033</ArticleId><ArticleId IdType="pmc">PMC10324553</ArticleId><ArticleId IdType="pubmed">36881788</ArticleId></ArticleIdList></Reference><Reference><Citation>Perricone C., Colafrancesco S., Mazor R.D., Soriano A., Agmon-Levin N., Shoenfeld Y. Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA) 2013: Unveiling the Pathogenic, Clinical and Diagnostic Aspects. J. Autoimmun. 2013;47:1–16. doi: 10.1016/j.jaut.2013.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2013.10.004</ArticleId><ArticleId IdType="pubmed">24238833</ArticleId></ArticleIdList></Reference><Reference><Citation>Trowsdale J., Knight J.C. Major Histocompatibility Complex Genomics and Human Disease. Annu. Rev. Genomics Hum. Genet. 2013;14:301–323. doi: 10.1146/annurev-genom-091212-153455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-genom-091212-153455</ArticleId><ArticleId IdType="pmc">PMC4426292</ArticleId><ArticleId IdType="pubmed">23875801</ArticleId></ArticleIdList></Reference><Reference><Citation>Tizaoui K., Shin J.I., Jeong G.H., Yang J.W., Park S., Kim J.H., Hwang S.Y., Park S.J., Koyanagi A., Smith L. Genetic Polymorphism of PTPN22 in Autoimmune Diseases: A Comprehensive Review. Medicina. 2022;58:1034. doi: 10.3390/medicina58081034.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58081034</ArticleId><ArticleId IdType="pmc">PMC9415475</ArticleId><ArticleId IdType="pubmed">36013501</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz J.T., Luján L., Blank M., Shoenfeld Y. Adjuvants- and Vaccines-Induced Autoimmunity: Animal Models. Immunol. Res. 2017;65:55–65. doi: 10.1007/s12026-016-8819-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-016-8819-5</ArticleId><ArticleId IdType="pubmed">27417999</ArticleId></ArticleIdList></Reference><Reference><Citation>HogenEsch H. Mechanisms of Stimulation of the Immune Response by Aluminum Adjuvants. Vaccine. 2002;20:S34–S39. doi: 10.1016/S0264-410X(02)00169-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0264-410X(02)00169-X</ArticleId><ArticleId IdType="pubmed">12184362</ArticleId></ArticleIdList></Reference><Reference><Citation>Demento S.L., Eisenbarth S.C., Foellmer H.G., Platt C., Caplan M.J., Mark Saltzman W., Mellman I., Ledizet M., Fikrig E., Flavell R.A., et al. Inflammasome-Activating Nanoparticles as Modular Systems for Optimizing Vaccine Efficacy. Vaccine. 2009;27:3013–3021. doi: 10.1016/j.vaccine.2009.03.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2009.03.034</ArticleId><ArticleId IdType="pmc">PMC2695996</ArticleId><ArticleId IdType="pubmed">19428913</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutterwala F.S., Ogura Y., Flavell R.A. The Inflammasome in Pathogen Recognition and Inflammation. J. Leukoc. Biol. 2007;82:259–264. doi: 10.1189/jlb.1206755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.1206755</ArticleId><ArticleId IdType="pubmed">17470531</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornung V., Bauernfeind F., Halle A., Samstad E.O., Kono H., Rock K.L., Fitzgerald K.A., Latz E. Silica Crystals and Aluminum Salts Activate the NALP3 Inflammasome through Phagosomal Destabilization. Nat. Immunol. 2008;9:847–856. doi: 10.1038/ni.1631.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.1631</ArticleId><ArticleId IdType="pmc">PMC2834784</ArticleId><ArticleId IdType="pubmed">18604214</ArticleId></ArticleIdList></Reference><Reference><Citation>Flach T.L., Ng G., Hari A., Desrosiers M.D., Zhang P., Ward S.M., Seamone M.E., Vilaysane A., Mucsi A.D., Fong Y., et al. Alum Interaction with Dendritic Cell Membrane Lipids Is Essential for Its Adjuvanticity. Nat. Med. 2011;17:479–487. doi: 10.1038/nm.2306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2306</ArticleId><ArticleId IdType="pubmed">21399646</ArticleId></ArticleIdList></Reference><Reference><Citation>Danielsson R., Eriksson H. Aluminium Adjuvants in Vaccines—A Way to Modulate the Immune Response. Semin. Cell Dev. Biol. 2021;115:3–9. doi: 10.1016/j.semcdb.2020.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2020.12.008</ArticleId><ArticleId IdType="pubmed">33423930</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen Tervaert J.W. Autoinflammatory/Autoimmunity Syndrome Induced by Adjuvants (ASIA; Shoenfeld’s Syndrome): A New Flame. Autoimmun. Rev. 2018;17:1259–1264. doi: 10.1016/j.autrev.2018.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2018.07.003</ArticleId><ArticleId IdType="pubmed">30316995</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Akl N.S., Chakhtoura M., Kazzi N.F., Usta J., Chamoun C.A., Abdelnoor A.M. Uric Acid; a Possible Mediator of the Adjuvant Effect of Alum in Mice Immunized with Ovalbumin. World J. Vaccines. 2011;01:148–155. doi: 10.4236/wjv.2011.14015.</Citation><ArticleIdList><ArticleId IdType="doi">10.4236/wjv.2011.14015</ArticleId></ArticleIdList></Reference><Reference><Citation>Marichal T., Ohata K., Bedoret D., Mesnil C., Sabatel C., Kobiyama K., Lekeux P., Coban C., Akira S., Ishii K.J., et al. DNA Released from Dying Host Cells Mediates Aluminum Adjuvant Activity. Nat. Med. 2011;17:996–1002. doi: 10.1038/nm.2403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2403</ArticleId><ArticleId IdType="pubmed">21765404</ArticleId></ArticleIdList></Reference><Reference><Citation>Coffman R.L., Sher A., Seder R.A. Vaccine Adjuvants: Putting Innate Immunity to Work. Immunity. 2010;33:492–503. doi: 10.1016/j.immuni.2010.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2010.10.002</ArticleId><ArticleId IdType="pmc">PMC3420356</ArticleId><ArticleId IdType="pubmed">21029960</ArticleId></ArticleIdList></Reference><Reference><Citation>Maisonneuve C., Bertholet S., Philpott D.J., De Gregorio E. Unleashing the Potential of NOD- and Toll-like Agonists as Vaccine Adjuvants. Proc. Natl. Acad. Sci. USA. 2014;111:12294–12299. doi: 10.1073/pnas.1400478111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1400478111</ArticleId><ArticleId IdType="pmc">PMC4151741</ArticleId><ArticleId IdType="pubmed">25136133</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooney R., Baker J., Brain O., Danis B., Pichulik T., Allan P., Ferguson D.J.P., Campbell B.J., Jewell D., Simmons A. NOD2 Stimulation Induces Autophagy in Dendritic Cells Influencing Bacterial Handling and Antigen Presentation. Nat. Med. 2010;16:90–97. doi: 10.1038/nm.2069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2069</ArticleId><ArticleId IdType="pubmed">19966812</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao T., Cai Y., Jiang Y., He X., Wei Y., Yu Y., Tian X. Vaccine Adjuvants: Mechanisms and Platforms. Signal Transduct. Target. Ther. 2023;8:283. doi: 10.1038/s41392-023-01557-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-023-01557-7</ArticleId><ArticleId IdType="pmc">PMC10356842</ArticleId><ArticleId IdType="pubmed">37468460</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehwinkel J., Gack M.U. RIG-I-like Receptors: Their Regulation and Roles in RNA Sensing. Nat. Rev. Immunol. 2020;20:537–551. doi: 10.1038/s41577-020-0288-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0288-3</ArticleId><ArticleId IdType="pmc">PMC7094958</ArticleId><ArticleId IdType="pubmed">32203325</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasumba D.M., Grandvaux N. Therapeutic Targeting of RIG-I and MDA5 Might Not Lead to the Same Rome. Trends Pharmacol. Sci. 2019;40:116–127. doi: 10.1016/j.tips.2018.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2018.12.003</ArticleId><ArticleId IdType="pmc">PMC7112877</ArticleId><ArticleId IdType="pubmed">30606502</ArticleId></ArticleIdList></Reference><Reference><Citation>Reikine S., Nguyen J.B., Modis Y. Pattern Recognition and Signaling Mechanisms of RIG-I and MDA5. Front. Immunol. 2014;5:342. doi: 10.3389/fimmu.2014.00342.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00342</ArticleId><ArticleId IdType="pmc">PMC4107945</ArticleId><ArticleId IdType="pubmed">25101084</ArticleId></ArticleIdList></Reference><Reference><Citation>Goretzki A., Lin Y.-J., Schülke S. Immune Metabolism in Allergies, Does It Matter?-A Review of Immune Metabolic Basics and Adaptations Associated with the Activation of Innate Immune Cells in Allergy. Allergy. 2021;76:3314–3331. doi: 10.1111/all.14843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14843</ArticleId><ArticleId IdType="pubmed">33811351</ArticleId></ArticleIdList></Reference><Reference><Citation>Obeso D., Mera-Berriatua L., Rodríguez-Coira J., Rosace D., Fernández P., Martín-Antoniano I.A., Santaolalla M., Marco Martín G., Chivato T., Fernández-Rivas M., et al. Multi-omics Analysis Points to Altered Platelet Functions in Severe Food-associated Respiratory Allergy. Allergy. 2018;73:2137–2149. doi: 10.1111/all.13563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.13563</ArticleId><ArticleId IdType="pubmed">30028518</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniel B., Nagy G., Czimmerer Z., Horvath A., Hammers D.W., Cuaranta-Monroy I., Poliska S., Tzerpos P., Kolostyak Z., Hays T.T., et al. The Nuclear Receptor PPARγ Controls Progressive Macrophage Polarization as a Ligand-Insensitive Epigenomic Ratchet of Transcriptional Memory. Immunity. 2018;49:615–626.e6. doi: 10.1016/j.immuni.2018.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2018.09.005</ArticleId><ArticleId IdType="pmc">PMC6197058</ArticleId><ArticleId IdType="pubmed">30332629</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T., Tibbitt C.A., Feng X., Stark J.M., Rohrbeck L., Rausch L., Sedimbi S.K., Karlsson M.C.I., Lambrecht B.N., Karlsson Hedestam G.B., et al. PPAR-γ Promotes Type 2 Immune Responses in Allergy and Nematode Infection. Sci. Immunol. 2017;2:eaal5196. doi: 10.1126/sciimmunol.aal5196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.aal5196</ArticleId><ArticleId IdType="pubmed">28783701</ArticleId></ArticleIdList></Reference><Reference><Citation>León B., Ballesteros-Tato A., Lund F.E. Dendritic Cells and B Cells: Unexpected Partners in Th2 Development. J. Immunol. Baltim. Md 1950. 2014;193:1531–1537. doi: 10.4049/jimmunol.1400149.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1400149</ArticleId><ArticleId IdType="pmc">PMC4233146</ArticleId><ArticleId IdType="pubmed">25086176</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho S.H., Raybuck A.L., Stengel K., Wei M., Beck T.C., Volanakis E., Thomas J.W., Hiebert S., Haase V.H., Boothby M.R. Germinal Centre Hypoxia and Regulation of Antibody Qualities by a Hypoxia Response System. Nature. 2016;537:234–238. doi: 10.1038/nature19334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature19334</ArticleId><ArticleId IdType="pmc">PMC5161594</ArticleId><ArticleId IdType="pubmed">27501247</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong L., He Y., Zhou S., Cao Y., Li Y., Bi Y., Liu G. HIF1α-Dependent Metabolic Signals Control the Differentiation of Follicular Helper T Cells. Cells. 2019;8:1450. doi: 10.3390/cells8111450.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8111450</ArticleId><ArticleId IdType="pmc">PMC6912655</ArticleId><ArticleId IdType="pubmed">31744227</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho S.H., Raybuck A.L., Blagih J., Kemboi E., Haase V.H., Jones R.G., Boothby M.R. Hypoxia-Inducible Factors in CD4+ T Cells Promote Metabolism, Switch Cytokine Secretion, and T Cell Help in Humoral Immunity. Proc. Natl. Acad. Sci. USA. 2019;116:8975–8984. doi: 10.1073/pnas.1811702116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1811702116</ArticleId><ArticleId IdType="pmc">PMC6500120</ArticleId><ArticleId IdType="pubmed">30988188</ArticleId></ArticleIdList></Reference><Reference><Citation>Son Y.M., Cheon I.S., Goplen N.P., Dent A.L., Sun J. Inhibition of Stearoyl-CoA Desaturases Suppresses Follicular Help T- and Germinal Center B- Cell Responses. Eur. J. Immunol. 2020;50:1067–1077. doi: 10.1002/eji.201948257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201948257</ArticleId><ArticleId IdType="pmc">PMC8496969</ArticleId><ArticleId IdType="pubmed">32133634</ArticleId></ArticleIdList></Reference><Reference><Citation>Israeli E., Agmon-Levin N., Blank M., Shoenfeld Y. Adjuvants and Autoimmunity. Lupus. 2009;18:1217–1225. doi: 10.1177/0961203309345724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203309345724</ArticleId><ArticleId IdType="pubmed">19880572</ArticleId></ArticleIdList></Reference><Reference><Citation>McAnally J.L., Xu L., Villain M., Blalock J.E. The Role of Adjuvants in the Efficacy of a Peptide Vaccine for Myasthenia Gravis. Exp. Biol. Med. Maywood NJ. 2001;226:307–311. doi: 10.1177/153537020122600407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/153537020122600407</ArticleId><ArticleId IdType="pubmed">11368422</ArticleId></ArticleIdList></Reference><Reference><Citation>Ott N., Faletti L., Heeg M., Andreani V., Grimbacher B. JAKs and STATs from a Clinical Perspective: Loss-of-Function Mutations, Gain-of-Function Mutations, and Their Multidimensional Consequences. J. Clin. Immunol. 2023;43:1326–1359. doi: 10.1007/s10875-023-01483-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-023-01483-x</ArticleId><ArticleId IdType="pmc">PMC10354173</ArticleId><ArticleId IdType="pubmed">37140667</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim W.A., Pawson T. Phosphotyrosine Signaling: Evolving a New Cellular Communication System. Cell. 2010;142:661–667. doi: 10.1016/j.cell.2010.08.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.08.023</ArticleId><ArticleId IdType="pmc">PMC2950826</ArticleId><ArticleId IdType="pubmed">20813250</ArticleId></ArticleIdList></Reference><Reference><Citation>Minegishi Y., Saito M., Tsuchiya S., Tsuge I., Takada H., Hara T., Kawamura N., Ariga T., Pasic S., Stojkovic O., et al. Dominant-Negative Mutations in the DNA-Binding Domain of STAT3 Cause Hyper-IgE Syndrome. Nature. 2007;448:1058–1062. doi: 10.1038/nature06096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06096</ArticleId><ArticleId IdType="pubmed">17676033</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruber C.N., Calis J.J.A., Buta S., Evrony G., Martin J.C., Uhl S.A., Caron R., Jarchin L., Dunkin D., Phelps R., et al. Complex Autoinflammatory Syndrome Unveils Fundamental Principles of JAK1 Kinase Transcriptional and Biochemical Function. Immunity. 2020;53:672–684.e11. doi: 10.1016/j.immuni.2020.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.07.006</ArticleId><ArticleId IdType="pmc">PMC7398039</ArticleId><ArticleId IdType="pubmed">32750333</ArticleId></ArticleIdList></Reference><Reference><Citation>Flanagan S.E., Haapaniemi E., Russell M.A., Caswell R., Allen H.L., De Franco E., McDonald T.J., Rajala H., Ramelius A., Barton J., et al. Activating Germline Mutations in STAT3 Cause Early-Onset Multi-Organ Autoimmune Disease. Nat. Genet. 2014;46:812–814. doi: 10.1038/ng.3040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3040</ArticleId><ArticleId IdType="pmc">PMC4129488</ArticleId><ArticleId IdType="pubmed">25038750</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz D.M., Bonelli M., Gadina M., O’Shea J.J. Type I/II Cytokines, JAKs, and New Strategies for Treating Autoimmune Diseases. Nat. Rev. Rheumatol. 2016;12:25–36. doi: 10.1038/nrrheum.2015.167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2015.167</ArticleId><ArticleId IdType="pmc">PMC4688091</ArticleId><ArticleId IdType="pubmed">26633291</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Shea J.J., Schwartz D.M., Villarino A.V., Gadina M., McInnes I.B., Laurence A. The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention. Annu. Rev. Med. 2015;66:311–328. doi: 10.1146/annurev-med-051113-024537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-051113-024537</ArticleId><ArticleId IdType="pmc">PMC5634336</ArticleId><ArticleId IdType="pubmed">25587654</ArticleId></ArticleIdList></Reference><Reference><Citation>Santoni M., Massari F., Del Re M., Ciccarese C., Piva F., Principato G., Montironi R., Santini D., Danesi R., Tortora G., et al. Investigational Therapies Targeting Signal Transducer and Activator of Transcription 3 for the Treatment of Cancer. Expert Opin. Investig. Drugs. 2015;24:809–824. doi: 10.1517/13543784.2015.1020370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/13543784.2015.1020370</ArticleId><ArticleId IdType="pubmed">25746129</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito S., Prada E., Mastrolia M.V., Tarantino G., Codecà C., Rigante D. Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA): Clues and Pitfalls in the Pediatric Background. Immunol. Res. 2014;60:366–375. doi: 10.1007/s12026-014-8586-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-014-8586-0</ArticleId><ArticleId IdType="pubmed">25395340</ArticleId></ArticleIdList></Reference><Reference><Citation>Facciolà A., Visalli G., Laganà A., Di Pietro A. An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives. Vaccines. 2022;10:819. doi: 10.3390/vaccines10050819.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10050819</ArticleId><ArticleId IdType="pmc">PMC9147349</ArticleId><ArticleId IdType="pubmed">35632575</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah R.R., Hassett K.J., Brito L.A. Overview of Vaccine Adjuvants: Introduction, History, and Current Status. In: Fox C.B., editor. Vaccine Adjuvants. Volume 1494. Springer; New York, NY, USA: 2017. pp. 1–13. Methods in Molecular Biology.</Citation><ArticleIdList><ArticleId IdType="pubmed">27718182</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y., Mehl F., Zeichner S.L. Vaccine Strategies to Elicit Mucosal Immunity. Vaccines. 2024;12:191. doi: 10.3390/vaccines12020191.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines12020191</ArticleId><ArticleId IdType="pmc">PMC10892965</ArticleId><ArticleId IdType="pubmed">38400174</ArticleId></ArticleIdList></Reference><Reference><Citation>Laera D., HogenEsch H., O’Hagan D.T. Aluminum Adjuvants—‘Back to the Future’. Pharmaceutics. 2023;15:1884. doi: 10.3390/pharmaceutics15071884.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics15071884</ArticleId><ArticleId IdType="pmc">PMC10383759</ArticleId><ArticleId IdType="pubmed">37514070</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan J., Jin S., Gilmartin L., Toth I., Hussein W.M., Stephenson R.J. Advances in Infectious Disease Vaccine Adjuvants. Vaccines. 2022;10:1120. doi: 10.3390/vaccines10071120.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10071120</ArticleId><ArticleId IdType="pmc">PMC9316175</ArticleId><ArticleId IdType="pubmed">35891284</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanuri S.H., Sirrkay P.J. Adjuvants in COVID-19 Vaccines: Innocent Bystanders or Culpable Abettors for Stirring up COVID-Heart Syndrome. Ther. Adv. Vaccines Immunother. 2024;12:25151355241228439. doi: 10.1177/25151355241228439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/25151355241228439</ArticleId><ArticleId IdType="pmc">PMC10846003</ArticleId><ArticleId IdType="pubmed">38322819</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda-Okubo Y., Barnard D., Ong C.H., Peng B.-H., Tseng C.-T.K., Petrovsky N. Severe Acute Respiratory Syndrome-Associated Coronavirus Vaccines Formulated with Delta Inulin Adjuvants Provide Enhanced Protection While Ameliorating Lung Eosinophilic Immunopathology. J. Virol. 2015;89:2995–3007. doi: 10.1128/JVI.02980-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02980-14</ArticleId><ArticleId IdType="pmc">PMC4337527</ArticleId><ArticleId IdType="pubmed">25520500</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng C.-T., Sbrana E., Iwata-Yoshikawa N., Newman P.C., Garron T., Atmar R.L., Peters C.J., Couch R.B. Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus. PLoS ONE. 2012;7:e35421. doi: 10.1371/annotation/2965cfae-b77d-4014-8b7b-236e01a35492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/annotation/2965cfae-b77d-4014-8b7b-236e01a35492</ArticleId><ArticleId IdType="pmc">PMC3335060</ArticleId><ArticleId IdType="pubmed">22536382</ArticleId></ArticleIdList></Reference><Reference><Citation>Power U.F., Huss T., Michaud V., Plotnicky-Gilquin H., Bonnefoy J.Y., Nguyen T.N. Differential Histopathology and Chemokine Gene Expression in Lung Tissues Following Respiratory Syncytial Virus (RSV) Challenge of Formalin-Inactivated RSV- or BBG2Na-Immunized Mice. J. Virol. 2001;75:12421–12430. doi: 10.1128/JVI.75.24.12421-12430.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.75.24.12421-12430.2001</ArticleId><ArticleId IdType="pmc">PMC116138</ArticleId><ArticleId IdType="pubmed">11711632</ArticleId></ArticleIdList></Reference><Reference><Citation>Gherardi R.K., Coquet M., Cherin P., Belec L., Moretto P., Dreyfus P.A., Pellissier J.F., Chariot P., Authier F.J. Macrophagic Myofasciitis Lesions Assess Long-Term Persistence of Vaccine-Derived Aluminium Hydroxide in Muscle. Brain J. Neurol. 2001;124:1821–1831. doi: 10.1093/brain/124.9.1821.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/124.9.1821</ArticleId><ArticleId IdType="pubmed">11522584</ArticleId></ArticleIdList></Reference><Reference><Citation>Gherardi R.K., Crépeaux G., Authier F.-J. Myalgia and Chronic Fatigue Syndrome Following Immunization: Macrophagic Myofasciitis and Animal Studies Support Linkage to Aluminum Adjuvant Persistency and Diffusion in the Immune System. Autoimmun. Rev. 2019;18:691–705. doi: 10.1016/j.autrev.2019.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2019.05.006</ArticleId><ArticleId IdType="pubmed">31059838</ArticleId></ArticleIdList></Reference><Reference><Citation>Calabro S., Tortoli M., Baudner B.C., Pacitto A., Cortese M., O’Hagan D.T., De Gregorio E., Seubert A., Wack A. Vaccine Adjuvants Alum and MF59 Induce Rapid Recruitment of Neutrophils and Monocytes That Participate in Antigen Transport to Draining Lymph Nodes. Vaccine. 2011;29:1812–1823. doi: 10.1016/j.vaccine.2010.12.090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2010.12.090</ArticleId><ArticleId IdType="pubmed">21215831</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuroda Y., Nacionales D.C., Akaogi J., Reeves W.H., Satoh M. Autoimmunity Induced by Adjuvant Hydrocarbon Oil Components of Vaccine. Biomed. Pharmacother. 2004;58:325–337. doi: 10.1016/j.biopha.2004.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2004.04.009</ArticleId><ArticleId IdType="pubmed">15194169</ArticleId></ArticleIdList></Reference><Reference><Citation>Skinner S.R., Szarewski A., Romanowski B., Garland S.M., Lazcano-Ponce E., Salmerón J., Del Rosario-Raymundo M.R., Verheijen R.H.M., Quek S.C., Da Silva D.P., et al. Efficacy, Safety, and Immunogenicity of the Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Women Older than 25 Years: 4-Year Interim Follow-up of the Phase 3, Double-Blind, Randomised Controlled VIVIANE Study. The Lancet. 2014;384:2213–2227. doi: 10.1016/S0140-6736(14)60920-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)60920-X</ArticleId><ArticleId IdType="pubmed">25189358</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbyn M., Xu L., Simoens C., Martin-Hirsch P.P. Prophylactic Vaccination against Human Papillomaviruses to Prevent Cervical Cancer and Its Precursors. Cochrane Database Syst. Rev. 2018;5:CD009069. doi: 10.1002/14651858.CD009069.pub3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD009069.pub3</ArticleId><ArticleId IdType="pmc">PMC6494566</ArticleId><ArticleId IdType="pubmed">29740819</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunasekaran M., Chatterjee P.K., Shih A., Imperato G.H., Addorisio M., Kumar G., Lee A., Graf J.F., Meyer D., Marino M., et al. Immunization Elicits Antigen-Specific Antibody Sequestration in Dorsal Root Ganglia Sensory Neurons. Front. Immunol. 2018;9:638. doi: 10.3389/fimmu.2018.00638.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00638</ArticleId><ArticleId IdType="pmc">PMC5932385</ArticleId><ArticleId IdType="pubmed">29755449</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert M.R., Harding B.L., Hoffman P.N., Griffin J.W., Price D.L., Troncoso J.C. Aluminum-Induced Neurofilamentous Changes in Cultured Rat Dorsal Root Ganglia Explants. J. Neurosci. 1992;12:1763–1771. doi: 10.1523/JNEUROSCI.12-05-01763.1992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.12-05-01763.1992</ArticleId><ArticleId IdType="pmc">PMC6575895</ArticleId><ArticleId IdType="pubmed">1578268</ArticleId></ArticleIdList></Reference><Reference><Citation>Colafrancesco S., Perricone C., Tomljenovic L., Shoenfeld Y. Human Papilloma Virus Vaccine and Primary Ovarian Failure: Another Facet of the Autoimmune/Inflammatory Syndrome Induced by Adjuvants. Am. J. Reprod. Immunol. 2013;70:309–316. doi: 10.1111/aji.12151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aji.12151</ArticleId><ArticleId IdType="pubmed">23902317</ArticleId></ArticleIdList></Reference><Reference><Citation>Little D.T., Ward H.R.G. Premature Ovarian Failure 3 Years after Menarche in a 16-Year-Old Girl Following Human Papillomavirus Vaccination. BMJ Case Rep. 2012;2012:bcr2012006879. doi: 10.1136/bcr-2012-006879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2012-006879</ArticleId><ArticleId IdType="pmc">PMC4543769</ArticleId><ArticleId IdType="pubmed">23035167</ArticleId></ArticleIdList></Reference><Reference><Citation>Jara L.J., Vera-Lastra O., Mahroum N., Pineda C., Shoenfeld Y. Autoimmune Post-COVID Vaccine Syndromes: Does the Spectrum of Autoimmune/Inflammatory Syndrome Expand? Clin. Rheumatol. 2022;41:1603–1609. doi: 10.1007/s10067-022-06149-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-022-06149-4</ArticleId><ArticleId IdType="pmc">PMC8979721</ArticleId><ArticleId IdType="pubmed">35378658</ArticleId></ArticleIdList></Reference><Reference><Citation>Pujol A., Gómez L.-A., Gallegos C., Nicolau J., Sanchís P., González-Freire M., López-González Á.A., Dotres K., Masmiquel L. Thyroid as a Target of Adjuvant Autoimmunity/Inflammatory Syndrome Due to mRNA-Based SARS-CoV2 Vaccination: From Graves’ Disease to Silent Thyroiditis. J. Endocrinol. Invest. 2022;45:875–882. doi: 10.1007/s40618-021-01707-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-021-01707-0</ArticleId><ArticleId IdType="pmc">PMC8598936</ArticleId><ArticleId IdType="pubmed">34792795</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan F., Brassill M.J. Subacute Thyroiditis Post-Pfizer-BioNTech mRNA Vaccination for COVID-19. Endocrinol. Diabetes Metab. Case Rep. 2021;2021:21-0142. doi: 10.1530/EDM-21-0142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EDM-21-0142</ArticleId><ArticleId IdType="pmc">PMC8686178</ArticleId><ArticleId IdType="pubmed">34907904</ArticleId></ArticleIdList></Reference><Reference><Citation>Siolos A., Gartzonika K., Tigas S. Thyroiditis Following Vaccination against COVID-19: Report of Two Cases and Review of the Literature. Metab. Open. 2021;12:100136. doi: 10.1016/j.metop.2021.100136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metop.2021.100136</ArticleId><ArticleId IdType="pmc">PMC8520171</ArticleId><ArticleId IdType="pubmed">34693241</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelmaksoud A., Wollina U., Temiz S.A., Hasan A. SARS-CoV-2 Vaccination-Induced Cutaneous Vasculitis: Report of Two New Cases and Literature Review. Dermatol. Ther. 2022;35:e15458. doi: 10.1111/dth.15458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dth.15458</ArticleId><ArticleId IdType="pmc">PMC9111803</ArticleId><ArticleId IdType="pubmed">35306713</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeffs L.S., Nitschke J., Tervaert J.W.C., Peh C.A., Hurtado P.R. Viral RNA in the Influenza Vaccine May Have Contributed to the Development of ANCA-Associated Vasculitis in a Patient Following Immunisation. Clin. Rheumatol. 2016;35:943–951. doi: 10.1007/s10067-015-3073-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-015-3073-0</ArticleId><ArticleId IdType="pubmed">26361945</ArticleId></ArticleIdList></Reference><Reference><Citation>Sachinidis A., Garyfallos A. COVID-19 Vaccination Can Occasionally Trigger Autoimmune Phenomena, Probably via Inducing Age-associated B Cells. Int. J. Rheum. Dis. 2022;25:83–85. doi: 10.1111/1756-185X.14238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.14238</ArticleId><ArticleId IdType="pmc">PMC8652459</ArticleId><ArticleId IdType="pubmed">34766739</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Xu Z., Wang P., Li X., Shuai Z., Ye D., Pan H. New-onset Autoimmune Phenomena post-COVID-19 Vaccination. Immunology. 2022;165:386–401. doi: 10.1111/imm.13443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.13443</ArticleId><ArticleId IdType="pubmed">34957554</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen Tervaert J.W., Martinez-Lavin M., Jara L.J., Halpert G., Watad A., Amital H., Shoenfeld Y. Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA) in 2023. Autoimmun. Rev. 2023;22:103287. doi: 10.1016/j.autrev.2023.103287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2023.103287</ArticleId><ArticleId IdType="pubmed">36738954</ArticleId></ArticleIdList></Reference><Reference><Citation>The Putative Role of Environmental Aluminium in the Development of Chronic Neuropathology in Adults and Children. How Strong Is the Evidence and What Could Be the Mechanisms Involved?|Metabolic Brain Disease.  [(accessed on 6 October 2024)].  Available online:  https://link.springer.com/article/10.1007/s11011-017-0077-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11011-017-0077-2</ArticleId><ArticleId IdType="pmc">PMC5596046</ArticleId><ArticleId IdType="pubmed">28752219</ArticleId></ArticleIdList></Reference><Reference><Citation>Zafrir Y., Agmon-Levin N., Paz Z., Shilton T., Shoenfeld Y. Autoimmunity Following Hepatitis B Vaccine as Part of the Spectrum of “Autoimmune (Auto-Inflammatory) Syndrome Induced by Adjuvants” (ASIA): Analysis of 93 Cases. Lupus. 2012;21:146–152. doi: 10.1177/0961203311429318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203311429318</ArticleId><ArticleId IdType="pubmed">22235045</ArticleId></ArticleIdList></Reference><Reference><Citation>Barilaro G., Spaziani Testa C., Cacciani A., Donato G., Dimko M., Mariotti A. ASIA Syndrome, Calcinosis Cutis and Chronic Kidney Disease Following Silicone Injections. A Case-Based Review. Immunol. Res. 2016;64:1142–1149. doi: 10.1007/s12026-016-8871-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-016-8871-1</ArticleId><ArticleId IdType="pubmed">27665458</ArticleId></ArticleIdList></Reference><Reference><Citation>Barroso da Silva E.A., Vásquez Ortiz L., Aragón Salleg C., Briceño Balcázar I., Tuta Quintero E., Urrea X., Gustavo Celis L., Pimentel J. Autoimmunity in Patients with Silicone Breast Implants: An Exploratory Review. Rev. Colomb. Reumatol. Engl. Ed. 2024;31:57–67. doi: 10.1016/j.rcreue.2022.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rcreue.2022.12.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Miro-Mur F., Hindié M., Kandhaya-Pillai R., Tobajas V., Schwartz S., Alijotas-Reig J. Medical-grade Silicone Induces Release of Proinflammatory Cytokines in Peripheral Blood Mononuclear Cells without Activating T Cells. J. Biomed. Mater. Res. B Appl. Biomater. 2009;90B:510–520. doi: 10.1002/jbm.b.31312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbm.b.31312</ArticleId><ArticleId IdType="pubmed">19145631</ArticleId></ArticleIdList></Reference><Reference><Citation>Littman E.R., Mccabe K., Beg S. Saline Breast Implant Associated With Inflammatory Arthritis and Positive Antinuclear Antibodies (ANA): A Case Report. Cureus. 2024;16:e55061. doi: 10.7759/cureus.55061.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.55061</ArticleId><ArticleId IdType="pmc">PMC10977612</ArticleId><ArticleId IdType="pubmed">38550431</ArticleId></ArticleIdList></Reference><Reference><Citation>Spit K.A., Scharff M., de Blok C.J., Niessen F.B., Bachour Y., Nanayakkara P.W. Patient-Reported Systemic Symptoms in Women with Silicone Breast Implants: A Descriptive Cohort Study. BMJ Open. 2022;12:e057159. doi: 10.1136/bmjopen-2021-057159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-057159</ArticleId><ArticleId IdType="pmc">PMC9185500</ArticleId><ArticleId IdType="pubmed">35680258</ArticleId></ArticleIdList></Reference><Reference><Citation>Bueno-Gardea V.M., Baeza-Ramos J.H., Avalos-Trejo O.A., Durán-Rodríguez A.G., Martínez-Acosta J.R., Baeza-Salcido M., de la Rosa I.A.A., Muñoz-Torres M., Abbud-Fitzmaurice M.F., Brito-Brito N.R., et al. Autoimmune/Inflammatory Syndrome Induced by Adjuvants: A Review. Int. J. Res. Med. Sci. 2023;11:3105–3109. doi: 10.18203/2320-6012.ijrms20232458.</Citation><ArticleIdList><ArticleId IdType="doi">10.18203/2320-6012.ijrms20232458</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavallasca J.A., Musuruana J.L., del Rosario Maliandi M. Clinical Manifestations, Laboratory Features, and Evolution in Patients with Autoimmune/Autoinflammatory Syndrome Induced by Adjuvants (ASIA) Rev. Colomb. Reumatol. Engl. Ed. 2024 doi: 10.1016/j.rcreue.2024.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rcreue.2024.08.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuéllar M.L., Scopelitis E., Tenenbaum S.A., Garry R.F., Silveira L.H., Cabrera G., Espinoza L.R. Serum Antinuclear Antibodies in Women with Silicone Breast Implants. J. Rheumatol. 1995;22:236–240.</Citation><ArticleIdList><ArticleId IdType="pubmed">7738944</ArticleId></ArticleIdList></Reference><Reference><Citation>Plavsic A., Arandjelovic S., Dimitrijevic M., Kusic N., Tomic Spiric V., Popovic B., Jovicic Z., Peric Popadic A., Miskovic R. Autoimmune/Inflammatory Syndrome Induced by Adjuvants in a Woman with Hashimoto Thyroiditis and Familial Autoimmunity—A Case Report and Literature Review. Front. Immunol. 2023;14:1139603. doi: 10.3389/fimmu.2023.1139603.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1139603</ArticleId><ArticleId IdType="pmc">PMC10242122</ArticleId><ArticleId IdType="pubmed">37287963</ArticleId></ArticleIdList></Reference><Reference><Citation>Maitani K., Kadowaki M., Yamagiwa Y., Yasuhara Y., Kozuki S., Otsuka Y., Kubo T., Tomita K. Three Case Reports of Adult-Onset Still Disease Associated with Breast Implantation. Plast. Reconstr. Surg. Glob. Open. 2024;12:e5844. doi: 10.1097/GOX.0000000000005844.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/GOX.0000000000005844</ArticleId><ArticleId IdType="pmc">PMC11111390</ArticleId><ArticleId IdType="pubmed">38784828</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes E Silva D., Gründler C., Spengler M.d.G.d.M.T., Horimoto A.M.C., Machado M.A., Frazão I.C., Takita L.C. Autoimmune Syndrome Induced by Adjuvants (ASIA) after Silicone Breast Augmentation Surgery. Plast. Reconstr. Surg. Glob. Open. 2017;5:e1487. doi: 10.1097/GOX.0000000000001487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/GOX.0000000000001487</ArticleId><ArticleId IdType="pmc">PMC5640359</ArticleId><ArticleId IdType="pubmed">29062654</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanev D., Marinchev L., Robeva R. Autoimmune/Auto-Inflammatory Syndrome Induced by Adjuvant (ASIA) in Patients Refusing Breast Implant Explantation: Two Case Reports and a Review of the Literature. Biotechnol. Biotechnol. Equip. 2023;37:7–13. doi: 10.1080/13102818.2022.2151377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13102818.2022.2151377</ArticleId></ArticleIdList></Reference><Reference><Citation>Alijotas-Reig J., Esteve-Valverde E., Gil-Aliberas N., Garcia-Gimenez V. Autoimmune/Inflammatory Syndrome Induced by Adjuvants-ASIA-Related to Biomaterials: Analysis of 45 Cases and Comprehensive Review of the Literature. Immunol. Res. 2018;66:120–140. doi: 10.1007/s12026-017-8980-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-017-8980-5</ArticleId><ArticleId IdType="pubmed">29199390</ArticleId></ArticleIdList></Reference><Reference><Citation>Chauhan U., Cassidy B., Cohen Tervaert J.W. ASIA (Shoenfeld’s Syndrome) Due to Hysteroscopic Essure Sterilization. Autoimmun. Rev. 2021;20:102979. doi: 10.1016/j.autrev.2021.102979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102979</ArticleId><ArticleId IdType="pubmed">34752966</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaz R.A., Xavier P., Brito S., Dantas J., Duque S., Consciência J.G., Campos L. Metallosis: A New Form of Autoimmune/Autoinflammatory Syndrome Induced by Adjuvants Syndrome (ASIA)? Eur. J. Case Rep. Intern. Med. 2019;6:1. doi: 10.12890/2019_001034.</Citation><ArticleIdList><ArticleId IdType="doi">10.12890/2019_001034</ArticleId><ArticleId IdType="pmc">PMC6438109</ArticleId><ArticleId IdType="pubmed">30931273</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiff A., Jiries N., Goldsztein S., Schiff E., Ginsberg S. A Possible Association of Orthopedic Metal Implants and ASIA Syndrome. Rheumatology. 2021;60:e95–e96. doi: 10.1093/rheumatology/keaa481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa481</ArticleId><ArticleId IdType="pubmed">33027521</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolfi A.L., Brown B.N., Liang R., Palcsey S.L., Bonidie M.J., Abramowitch S.D., Moalli P.A. Host Response to Synthetic Mesh in Women with Mesh Complications. Am. J. Obstet. Gynecol. 2016;215:e1–e206. doi: 10.1016/j.ajog.2016.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2016.04.008</ArticleId><ArticleId IdType="pmc">PMC5201165</ArticleId><ArticleId IdType="pubmed">27094962</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung M.K., House J.S., Akhtari F.S., Makris K.C., Langston M.A., Islam K.T., Holmes P., Chadeau-Hyam M., Smirnov A.I., Du X., et al. Decoding the Exposome: Data Science Methodologies and Implications in Exposome-Wide Association Studies (ExWASs) Exposome. 2024;4:osae001. doi: 10.1093/exposome/osae001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/exposome/osae001</ArticleId><ArticleId IdType="pmc">PMC10857773</ArticleId><ArticleId IdType="pubmed">38344436</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeulen R., Schymanski E.L., Barabási A.-L., Miller G.W. The Exposome and Health: Where Chemistry Meets Biology. Science. 2020;367:392–396. doi: 10.1126/science.aay3164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aay3164</ArticleId><ArticleId IdType="pmc">PMC7227413</ArticleId><ArticleId IdType="pubmed">31974245</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung M.K., Rappaport S.M., Wheelock C.E., Nguyen V.K., van der Meer T.P., Miller G.W., Vermeulen R., Patel C.J. Utilizing a Biology-Driven Approach to Map the Exposome in Health and Disease: An Essential Investment to Drive the Next Generation of Environmental Discovery. Environ. Health Perspect. 2021;129:85001. doi: 10.1289/EHP8327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1289/EHP8327</ArticleId><ArticleId IdType="pmc">PMC8388254</ArticleId><ArticleId IdType="pubmed">34435882</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahad O., Al-Kindi S., Lelieveld J., Münzel T., Daiber A. Supporting and Implementing the Beneficial Parts of the Exposome: The Environment Can Be the Problem, but It Can Also Be the Solution. Int. J. Hyg. Environ. Health. 2024;255:114290. doi: 10.1016/j.ijheh.2023.114290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijheh.2023.114290</ArticleId><ArticleId IdType="pubmed">37979229</ArticleId></ArticleIdList></Reference><Reference><Citation>Alijotas-Reig J., Garcia-Gimenez V., Vilardell-Tarrés M. Tacrolimus in the Treatment of Chronic and Refractory Late-Onset Immune-Mediated Adverse Effects Related to Silicone Injections. Dermatol. Surg. Off. Publ. Am. Soc. Dermatol. Surg. Al. 2012;38:38–47. doi: 10.1111/j.1524-4725.2011.02221.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1524-4725.2011.02221.x</ArticleId><ArticleId IdType="pubmed">22122552</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasin L., Cavalli G., Navalesi P., Sella N., Landoni G., Yavorovskiy A.G., Likhvantsev V.V., Zangrillo A., Dagna L., Monti G. Anakinra for Patients with COVID-19: A Meta-Analysis of Non-Randomized Cohort Studies. Eur. J. Intern. Med. 2021;86:34–40. doi: 10.1016/j.ejim.2021.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.01.016</ArticleId><ArticleId IdType="pmc">PMC7862887</ArticleId><ArticleId IdType="pubmed">33581979</ArticleId></ArticleIdList></Reference><Reference><Citation>Forbes L.R., Vogel T.P., Cooper M.A., Castro-Wagner J., Schussler E., Weinacht K.G., Plant A.S., Su H.C., Allenspach E.J., Slatter M., et al. Jakinibs for the Treatment of Immune Dysregulation in Patients with Gain-of-Function Signal Transducer and Activator of Transcription 1 (STAT1) or STAT3 Mutations. J. Allergy Clin. Immunol. 2018;142:1665–1669. doi: 10.1016/j.jaci.2018.07.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2018.07.020</ArticleId><ArticleId IdType="pmc">PMC6322659</ArticleId><ArticleId IdType="pubmed">30092289</ArticleId></ArticleIdList></Reference><Reference><Citation>Moni S.S., Abdelwahab S.I., Jabeen A., Elmobark M.E., Aqaili D., Gohal G., Oraibi B., Farasani A.M., Jerah A.A., Alnajai M.M.A., et al. Advancements in Vaccine Adjuvants: The Journey from Alum to Nano Formulations. Vaccines. 2023;11:1704. doi: 10.3390/vaccines11111704.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11111704</ArticleId><ArticleId IdType="pmc">PMC10674458</ArticleId><ArticleId IdType="pubmed">38006036</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymeric Nanoparticle-Based Vaccine Adjuvants and Delivery Vehicles|SpringerLink.  [(accessed on 6 October 2024)].  Available online:  https://link.springer.com/chapter/10.1007/82_2020_226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/82_2020_226</ArticleId></ArticleIdList></Reference><Reference><Citation>Full Article: Nanoparticles: Augmenting Tumor Antigen Presentation for Vaccine and Immunotherapy Treatments of Cancer.  [(accessed on 6 October 2024)].  Available online:  https://www.tandfonline.com/doi/full/10.2217/nnm-2017-0254.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/nnm-2017-0254</ArticleId><ArticleId IdType="pmc">PMC5704090</ArticleId><ArticleId IdType="pubmed">29098928</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleemi M.A., Zhang Y., Zhang G. Current Progress in the Science of Novel Adjuvant Nano-Vaccine-Induced Protective Immune Responses. Pathogens. 2024;13:441. doi: 10.3390/pathogens13060441.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens13060441</ArticleId><ArticleId IdType="pmc">PMC11206999</ArticleId><ArticleId IdType="pubmed">38921739</ArticleId></ArticleIdList></Reference><Reference><Citation>Virus-like Particle Vaccinology, from Bench to Bedside|Cellular &amp; Molecular Immunology.  [(accessed on 6 October 2024)].  Available online:  https://www.nature.com/articles/s41423-022-00897-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9371956</ArticleId><ArticleId IdType="pubmed">35962190</ArticleId></ArticleIdList></Reference><Reference><Citation>Safety of Vaccine Adjuvants: Focus on Autoimmunity—ScienceDirect.  [(accessed on 3 October 2024)].  Available online:  https://www.sciencedirect.com/science/article/pii/S0264410X15001309.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>